
Sign up to save your podcasts
Or
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001161?ecd=bdc_podcast_libsyn_mscpedu
4.3
2323 ratings
Join the experts for an in-depth discussion on the latest developments in targeted therapies for relapsed/refractory chronic lymphocytic leukemia (R/R CLL), and a look ahead to the upcoming EHA2024 conference. Credit available for this activity expires: 6/6/2025 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/1001161?ecd=bdc_podcast_libsyn_mscpedu
13 Listeners
313 Listeners
107 Listeners
172 Listeners
864 Listeners
494 Listeners
689 Listeners
18 Listeners
278 Listeners
255 Listeners
3,320 Listeners
137 Listeners
1,111 Listeners
8,004 Listeners
194 Listeners
60 Listeners
8 Listeners
425 Listeners
315 Listeners